Skip to content

Change in AP at other companies

Pfizer logo
PfizerPFE
-$117.25M+54.2%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$2.81M+382%
CG Oncology logo
CG OncologyCGON
$2.52M+1,079%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
-$5.68M-31.8%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$2.82M+898%
Arcus Biosciences logo
Arcus BiosciencesRCUS
-$3M-200%

Other financials

Income statement

See full
Operating income-$39.6M-21.1%
Net income-$35.8M-19.1%
EPS (diluted)-$0.34+19.0%

Balance sheet

See full
Cash & equivalents$56.4M+14.3%
Total debt$3.3M+2.6%
Total equity$415.6M+89.1%
Total assets$436.8M+79.8%

Cash flow

See full
Operating cash flow-$32.4M+0.3%
CapEx$2.0K-99.5%
Free cash flow-$32.4M+1.5%

Valuation

See full
Market cap$976.17M+23.0%
Enterprise value$923.07M+23.5%

Returns & leverage

See full
Return on equity-42.6%-4.6pp
Debt / equity0.0×
Current ratio16.3×+4.3×

Where this comes from

Reported directly by Oric Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oric Pharmaceuticals, Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oric Pharmaceuticals, Inc.'s change in AP?
Oric Pharmaceuticals, Inc. (ORIC) reported change in AP of -$3.32M in Q1 2026.
How has Oric Pharmaceuticals, Inc.'s change in AP changed year-over-year?
Oric Pharmaceuticals, Inc.'s change in AP increased by 58.0% year-over-year, from -$7.91M to -$3.32M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.